“showed a trend”

Larger PFO diameter (≥ 2.5 mm) showed a trend toward lower LA volume indices and E/e′, although differences were not statistically significant.

Social interactions with family and friends (AOR = 1.80, 95% CI: 0.94–3.45, p = 0.08) also showed a trend toward increased likelihood, though not statistically significant.

Its power generation output increased monotonically with a relatively slow growth rate, while the power generation efficiency showed a trend of rising first and then falling.

In this transition cohort, TaTME and R-TME achieved comparable short-term oncologic and survival outcomes; R-TME offered perioperative advantages, while TaTME showed a trend toward a longer distal margin that warrants cautious interpretation.

Renal function, assessed by eGFR, showed a trend toward improvement, which is encouraging in a population at increased risk for chronic kidney disease due to metabolic comorbidities.

Knowledge of HBV infection showed a trend toward increased uptake, but the association was not statistically significant (adjusted OR = 1.38, 95% CI: 0.96–2.00).

In contrast, the expression of MYC_3 showed a trend of first increasing and then decreasing (Figure 4g ).

As the promoter fragment was progressively truncated, the LUC/REN ratio showed a trend of increasing–decreasing–increasing, indicating the presence of suppressor elements during the −665 bp to −1422 bp region (Figure S8C ).

Indeed, when the analysis was adjusted for MSA phenotype values only showed a trend, not statistically significant.

In these zebrafish, tardbp A379T/− showed a trend in lower Tdp‐43 expression levels and expression was significantly reduced in tardbp G347C/− with concomitant increased expression of Tdp‐43‐like V1.

As for the intermediate of 6H-DBT, its concentration showed a trend of first increasing and then decreasing with the advancement of the reaction time in different reaction temperature ranges.

Equivalent results were observed with lomitapide treatment in the Pan-European Lomitapide Study [ 24 ], which also showed a trend toward a greater reduction in LDL-C in HoFH female compared with males after 6 months of lomitapide treatment.

The intensity of these absorption peaks showed a trend of first decreasing and then increasing before glycine leaching, after leaching, and after CO 2 mineralization.

Two randomized Phase II trials in non–small cell lung cancer [ 18 , 19 ] demonstrated that RT administered before or concurrently with anti–PD‐1 antibody prolonged PFS and showed a trend toward improved OS compared with ICI alone, with pooled analyses reporting a hazard ratio of 0.67 for both PFS and OS [ 20 ].

Egr3 also showed a trend of upregulation with a log 2 (fold change) value of ∼1, but it was insignificant due to low expression and high variability.

Similarly, vGlut2 and mGluR1 showed a trend toward increased expression in the VDD group compared to the VD‐ hypo and VD‐ hyper groups, although these changes did not reach statistical significance (Figure 5L,M , one‐way ANOVA with Tukey's multiple comparisons post hoc test).

Whilst trypsin and hyaluronidase treatment showed a trend toward increased IFN‐γ‐secreting CAR T cells, the differences did not reach statistical significance, likely due to the inherent variability in IFN‐γ measurements (Figure 4F ).

Finally, tolerogenic CCR7 + CD69 +/– CD103 +/– NK cells were significantly reduced, while transitional and cytotoxic NK cells showed a trend toward increased presence in the colorectal tissue after galunisertib ( Figure 7D ).

All groups showed a decline in antibody levels from V3 to V4, which was statistically significant in CTRLs and showed a trend in CKD and HD/PD patients, but not in KTRs.

Overall, expression of activation and adhesion markers on LN CD4 + T cells showed a trend toward recovery following T-MSC administration in DNCB-treated mice, although these changes did not reach statistical significance ( Fig 5E ).

The relative change in TST, as measured with the MI, showed a trend from underestimation of TST with sleep diary at baseline to being accurate or overestimating TST across sessions, and was significantly decreased by post-treatment.

We found that ART optimization showed a trend toward improved VL suppression (risk ratio [RR] 1.81, 95% CI: 0.79–4.14).

Results Female players had lower AT thickness compared to males and showed a trend toward lower stiffness.

However, continuous administration of midazolam showed a trend toward fewer body movements and a higher proportion of patients maintaining conscious sedation throughout the procedure, suggesting a potential benefit in terms of procedural stability.

Notably, EIS showed a trend towards an initial increase after five TS before subsequently decreasing, suggesting that EIS may be sensitive to different structural alterations than TEWL.